Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC October Update

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Sitagliptin (Januvia®) has been accepted for restricted use in patients with type 2 diabetes. It is recommended that this agent is used in patients where diet and exercise combined with metformin does not provide adequate glycaemic control and sulphonylureas are contraindicated or not tolerated. They should be considered an alternative to glitazones.

Escitalopram (Cipralex®) has been rejected for the treatment of obsessive compulsive disorder. The economic data submitted was not sufficiently robust to gain acceptance.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.

Share 'SMC October Update' on Email Share 'SMC October Update' on Delicious Share 'SMC October Update' on Digg Share 'SMC October Update' on Facebook Share 'SMC October Update' on Google+ Share 'SMC October Update' on reddit Share 'SMC October Update' on StumbleUpon Share 'SMC October Update' on Twitter

atomic-wealth

No Comments to “SMC October Update”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,615 spam comments.

atomic-wealth
fond-illness
summer